Real-world evidence/ Health Economics and Outcomes Research:
Biopharmaceutical manufacturers are turning to health economics and outcomes research (HEOR) to obtain real-world evidence (RWE) that can support and improve their drugs. Using HEOR to gather RWE helps biopharma companies address three forces reshaping how they do business:
- Competition in the biopharmaceutical manufacturing industry
- Interest from regulators, policymakers and patient advocacy groups
- Incentives from payers to enter into value-based contracts that base payment on outcomes